查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466248

高流量氧气鼻管市场：按组件、适应症和最终用户划分 - 全球预测 2024-2030

High-flow Nasal Cannula Market by Component (Active Humidifier, Air Oxygen Blender, Heated Inspiratory Circuit), Indication (Acute Heart Failure, Acute Respiratory Failure, Bronchiectasis), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

高流量氧气鼻管市场规模预估2023年为31.1亿美元，2024年达33.8亿美元，预计2030年将达到57.6亿美元，复合年增长率为9.17%。

高流量氧气鼻管市场包括医疗设备和配件，用于以高达每分钟 60 公升的各种流量输送适当加热和加湿的医用气体。 HFNC 治疗设备主要用于临床环境中治疗患有急性呼吸衰竭、慢性阻塞性肺病(COPD) 和其他呼吸系统疾病的患者。全球呼吸系统疾病盛行率不断上升，以及人们对 HFNC 治疗益处的认识不断提高，显着增加了对高流量氧气鼻管的需求。然而，采购和营运 HFNC 设备的高成本可能是一个主要障碍，特别是在成本敏感的市场。此外，医疗设备严格的监管要求可能会阻碍我们产品的市场进入并延迟上市时间。此外，技术进步以及携带式和家用 HFNC 设备的开拓可以为市场成长提供重大的成长机会。

主要市场统计
基准年[2023] 31.1亿美元
预测年份 [2024] 33.8亿美元
预测年份 [2030] 57.6亿美元
复合年增长率（%） 9.17%

组件：大量采用空气氧气混合器，提供精确调节氧气浓度的关键能力

主动加湿器在高流量氧气鼻管(HFNC) 系统中至关重要，因为它们透过添加必要的水分来调节气体，防止黏膜干燥并维持黏膜纤维功能。主动加湿系统通常由一个水室组成，在将气体输送给​​患者之前，水室被加热以添加水分。空气氧气混合器可以精确混合空气和氧气，为患者提供特定且恆定分数的吸入氧 (FiO2)。准确的 FiO2 对于管理患者的氧合状态、同时最大限度地降低高氧血症风险至关重要。

加热进气迴路用于维持从加湿器到患者的加湿气体的温度。这可以防止冷凝并在空气输送过程中保持最佳湿度水平。氧气鼻管是将加热和加湿的气体混合物输送给患者的介面。氧气鼻管的设计和舒适度非常重要，因为它直接影响患者对治疗的耐受性。

最终用户：医院中高流量氧气鼻管的使用增加，以支持广泛的患者和临床场景。

HFNC 系统是门诊医疗中心的首选，因为它们易于使用、便携且经济高效。这些中心为需要立即但不一定是医院级的密集治疗的患者提供服务。这些中心越来越偏好HFNC，因为它能够有效治疗急性呼吸衰竭等疾病，并且能够快速康復，这与门诊病人护理的目标非常吻合。医院是 HFNC 系统的主要用户，需要多种功能来适应从新生儿到成人的各种患者状况。医院正在寻找一种可以整合到现有工作流程中、提供高精度氧气输送并可用于各种部门（包括急诊、ICU 和普通病房）的系统。在长期照护中心，HFNC 系统必须易于使用且营运成本低。由于这些中心经常治疗慢性呼吸道疾病，因此 HFNC 系统必须适合长期使用。

区域洞察

美洲地区慢性阻塞性肺病(COPD) 和其他呼吸系统疾病的盛行率很高，因此 HFNC 设备的利用率很高。客户购买行为倾向于优先考虑品质和效果，更愿意投资高端设备。主要製造商和完善的医疗设施的存在也有助于该地区的高采用率。亚太地区的医疗保健产业正在经历强劲成长，特别是由于慢性呼吸道疾病的盛行率不断上升。中国、日本和印度等国家的消费者对先进呼吸支援设备（包括高流量氧气鼻管(HFNC)）的需求显着增加。这一增长是由人口老化、污染水平上升和医疗保健支出所推动的。在发达的医疗保健系统和不断上涨的医疗成本的推动下，欧洲对 HFNC 设备的需求持续强劲。欧盟国家对医疗设备监管严格、标准高，市场进入难度高，但保证了产品的高品质。中东和非洲 (MEA) 的市场动态不同，中东地区对医疗基础设施的投资不断增加，先进医疗技术的采用不断增加，而非洲 HFNC 市场正处于起步阶段，预计将因不断增加的增长而增长。呼吸解决方案。

FPNV定位矩阵

FPNV定位矩阵对于评估高流量氧气鼻管市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对高流量氧气鼻管市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.高流量氧气鼻管市场规模及预测如何？

2.高流量氧气鼻管市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3.高流量氧气鼻管市场的技术趋势和法规结构是什么？

4.高流量氧气鼻管市场主要供应商的市场占有率为何？

5. 进入高流量氧气鼻管市场适合的型态与策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 急性呼吸衰竭和睡眠呼吸中止症的盛行率增加
      • 增加 HFNC 在儿童支气管炎和肺炎治疗的使用
      • 居家照护中对非侵入性通气和持续性呼吸道正压的需求不断增加
    • 抑制因素
      • 与传统插管相比相对昂贵
    • 机会
      • 高流量氧气鼻管的技术进步
      • 支持商业化的有利法规结构
    • 任务
      • 与无人监督使用高流量氧气鼻管相关的方式和併发症
  • 市场区隔分析
    • 组件：大量采用空气氧气混合器，提供精确调节氧气水平的关键能力
    • 最终用户：高流量氧气鼻管越来越多地在医院中使用，以支持广泛的患者和临床场景。
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章高流量氧气鼻管市场：依组成部分

  • 主动加湿器
  • 空气氧气混合机
  • 加热进气迴路
  • 氧气鼻管

第七章依适应症分類的高流量氧气鼻管市场

  • 急性心臟衰竭
  • 急性呼吸衰竭
  • 支气管扩张
  • 一氧化碳毒性
  • 慢性阻塞性肺病

第八章高流量氧气鼻管市场：依最终用户分类

  • 门诊治疗中心
  • 医院
  • 长期照护中心

第九章北美及南美高流量氧气鼻管市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区高流量氧气鼻管市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲高流量氧气鼻管市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 新的细支气管炎试验开始探索婴儿的最佳呼吸支持
    • Teresa 的 Bonhawa Flow氧气疗法系统获得 FDA核准
    • Mercy Flight 为患有高风险呼吸道疾病的患者推出高流量氧气鼻管

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-437E9896A57C

[187 Pages Report] The High-flow Nasal Cannula Market size was estimated at USD 3.11 billion in 2023 and expected to reach USD 3.38 billion in 2024, at a CAGR 9.17% to reach USD 5.76 billion by 2030.

The market for high-flow nasal cannulas includes medical devices and accessories used to deliver adequately heated and humidified medical gas at a variety of flows up to 60 liters per minute. HFNC therapy devices are primarily used in clinical settings for patients suffering from acute respiratory failure, chronic obstructive pulmonary disease (COPD), and other respiratory illnesses. The rising incidence of respiratory diseases worldwide and growing awareness of the benefits of HFNC therapy are significantly increasing the demand for high-flow nasal cannulas. However, the high costs associated with procuring and operating HFNC devices can be a significant barrier, especially in cost-sensitive markets. Additionally, stringent regulatory requirements for medical devices can impede market entry and slow product launch times. Furthermore, technological advancements and the development of portable and home-use HFNC devices can offer significant growth opportunities for the market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.11 billion
Estimated Year [2024] USD 3.38 billion
Forecast Year [2030] USD 5.76 billion
CAGR (%) 9.17%

Component: significant adoption of air oxygen blenders to provide critical functionality of precisely adjusting oxygen levels

Active humidifiers are integral to high-flow nasal cannula (HFNC) systems as they condition the gas by adding the necessary moisture, thus preventing mucosal drying and maintaining mucociliary function. The active humidification system usually consists of a water chamber that heats up to add moisture to the gas before it is delivered to the patient. Air oxygen blenders allow for precise mixing of air and oxygen to deliver a specific and consistent fraction of inspired oxygen (FiO2) to the patient. Accurate FiO2 is crucial in managing the patient's oxygenation status while minimizing the risk of hyperoxia.

Heated inspiratory circuits are used to maintain the temperature of the humidified gas as it travels from the humidifier to the patient. It prevents condensation and ensures the optimal humidity level is maintained throughout delivery. The nasal cannula is the interface through which the heated and humidified gas mixture is delivered to the patient. The design and comfort of the nasal cannula are critical, as they directly impact the patient's tolerance to the therapy.

End User: Growing use of high-flow nasal cannula in hospitals for supporting a wide range of patients and clinical scenarios.

Ambulatory care centers prioritize HFNC systems that are easy to use, portable, and cost-effective. They cater to patients requiring immediate but not necessarily intensive hospitalization-level care. These centers have a growing preference for HFNC due to its efficacy in treating conditions such as acute respiratory failure and its role in rapid recovery, which aligns well with outpatient care objectives. Hospitals are the primary users of HFNC systems, requiring a range of functionalities to cater to diverse patient acuities, from neonates to adults. Hospitals seek systems that can be integrated into their existing workflows, offer precision in oxygen delivery, and can be used across different departments such as emergency rooms, ICUs, and regular wards. For long-term care centers, HFNC systems must be user-friendly and have low operating costs. As these centers often deal with chronic respiratory conditions, the HFNC systems must be suited for prolonged use.

Regional Insights

The Americas region has significant usage of HFNC devices due to the high prevalence of Chronic Obstructive Pulmonary Disease (COPD) and other respiratory illnesses. Customer purchasing behavior tends to prioritize quality and efficacy, with a willingness to invest in premium devices. The presence of leading manufacturers and well-established healthcare facilities contributes to the high adoption rates in the region. The Asia Pacific region has been marked by robust growth in the healthcare sector, particularly in response to the rising prevalence of chronic respiratory diseases. Countries such as China, Japan, and India have witnessed a notable increase in consumer demand for advanced respiratory support devices, including high-flow nasal cannula (HFNC). This growth is driven by the aging population, rising pollution levels, and healthcare spending. Europe continues to show strong demand for HFNC devices, driven by a well-developed healthcare system and increased healthcare expenditure. EU countries possess strict regulations and high standards for medical devices, making market entry challenging but ensuring high-quality products. The Middle East and Africa (MEA) have varied market dynamics, with the Middle East exhibiting rising investments in healthcare infrastructure and increasing adoption of advanced medical technologies, while Africa's HFNC market is at a nascent stage but expected to grow due to the rising need for respiratory solutions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the High-flow Nasal Cannula Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the High-flow Nasal Cannula Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the High-flow Nasal Cannula Market, highlighting leading vendors and their innovative profiles. These include Allied Medical Limited, Armstrong Medical Limited, BMC Medical Co., Ltd., Dragerwerk AG & Co. KGaA, Fairmont Medical Products Pty Ltd., Fisher & Paykel Healthcare Corporation Limited, Flexicare (Group) Limited, Great Group Medical Co., Ltd., Guangdong Pigeon Medical Apparatus Co.,Ltd., Hamilton Medical AG, Heka Medicals India Private Limited, ICU Medical, Inc., Koninklijke Philips N.V., Masimo Corporation, MEKICS Co., Ltd., Narang Medical Limited, nice Neotech Medical Systems Pvt. Ltd., ResMed, Inc., Sterimed Group, SunMed, LLC, Synergy Intact Private Limited, Teleflex Incorporated, Vapotherm, Inc., Vyaire Medical, Inc., and Well Lead Medical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the High-flow Nasal Cannula Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Active Humidifier
    • Air Oxygen Blender
    • Heated Inspiratory Circuit
    • Nasal Cannula
  • Indication
    • Acute Heart Failure
    • Acute Respiratory Failure
    • Bronchiectasis
    • Carbon Monoxide Toxicity
    • Chronic Obstructive Pulmonary Disease
  • End User
    • Ambulatory Care Centers
    • Hospitals
    • Long-Term Care Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the High-flow Nasal Cannula Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the High-flow Nasal Cannula Market?

3. What are the technology trends and regulatory frameworks in the High-flow Nasal Cannula Market?

4. What is the market share of the leading vendors in the High-flow Nasal Cannula Market?

5. Which modes and strategic moves are suitable for entering the High-flow Nasal Cannula Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Acute Respiratory Failures and Sleep Apnea
      • 5.1.1.2. Increasing Utilization of HFNC in the Treatment of Bronchitis and Pneumonia Among Children
      • 5.1.1.3. Rising need for Non-Invasive Ventilation and Continuous Positive Airway Pressure in Home Care Settings
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively High Cost Compared to Traditional Cannula
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in High-Flow Nasal Cannula
      • 5.1.3.2. Favorable Regulatory Framework Supporting Commercialization
    • 5.1.4. Challenges
      • 5.1.4.1. Modalities and Complications Associated With Unmonitored Use of High-Flow Nasal Cannula
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: significant adoption of air oxygen blenders to provide critical functionality of precisely adjusting oxygen levels
    • 5.2.2. End User: Growing use of high-flow nasal cannula in hospitals for supporting a wide range of patients and clinical scenarios.
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. High-flow Nasal Cannula Market, by Component

  • 6.1. Introduction
  • 6.2. Active Humidifier
  • 6.3. Air Oxygen Blender
  • 6.4. Heated Inspiratory Circuit
  • 6.5. Nasal Cannula

7. High-flow Nasal Cannula Market, by Indication

  • 7.1. Introduction
  • 7.2. Acute Heart Failure
  • 7.3. Acute Respiratory Failure
  • 7.4. Bronchiectasis
  • 7.5. Carbon Monoxide Toxicity
  • 7.6. Chronic Obstructive Pulmonary Disease

8. High-flow Nasal Cannula Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Care Centers
  • 8.3. Hospitals
  • 8.4. Long-Term Care Centers

9. Americas High-flow Nasal Cannula Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific High-flow Nasal Cannula Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa High-flow Nasal Cannula Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. New Bronchiolitis Trial Launched to Seek The Best Breathing Support For Babies
    • 12.3.2. Telesair Secures FDA Nod For Bonhawa Flow Oxygen Therapy System
    • 12.3.3. Mercy Flights Implementing High-Flow Nasal Cannula for High-Risk Respiratory Illness

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. HIGH-FLOW NASAL CANNULA MARKET RESEARCH PROCESS
  • FIGURE 2. HIGH-FLOW NASAL CANNULA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HIGH-FLOW NASAL CANNULA MARKET DYNAMICS
  • FIGURE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. HIGH-FLOW NASAL CANNULA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. HIGH-FLOW NASAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HIGH-FLOW NASAL CANNULA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACTIVE HUMIDIFIER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACTIVE HUMIDIFIER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AIR OXYGEN BLENDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AIR OXYGEN BLENDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HEATED INSPIRATORY CIRCUIT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HEATED INSPIRATORY CIRCUIT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY NASAL CANNULA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY NASAL CANNULA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE RESPIRATORY FAILURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE RESPIRATORY FAILURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CARBON MONOXIDE TOXICITY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CARBON MONOXIDE TOXICITY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 291. HIGH-FLOW NASAL CANNULA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 292. HIGH-FLOW NASAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2023